176 related articles for article (PubMed ID: 35814402)
1. Development and Validation of a DeepSurv Nomogram to Predict Survival Outcomes and Guide Personalized Adjuvant Chemotherapy in Non-Small Cell Lung Cancer.
Yang B; Liu C; Wu R; Zhong J; Li A; Ma L; Zhong J; Yin S; Zhou C; Ge Y; Tao X; Zhang L; Lu G
Front Oncol; 2022; 12():895014. PubMed ID: 35814402
[TBL] [Abstract][Full Text] [Related]
2. Development and validation of machine learning models for predicting prognosis and guiding individualized postoperative chemotherapy: A real-world study of distal cholangiocarcinoma.
Wang D; Pan B; Huang JC; Chen Q; Cui SP; Lang R; Lyu SC
Front Oncol; 2023; 13():1106029. PubMed ID: 37007095
[TBL] [Abstract][Full Text] [Related]
3. Development and Validation of a Radiomics Nomogram Based on
Yang B; Zhong J; Zhong J; Ma L; Li A; Ji H; Zhou C; Duan S; Wang Q; Zhu C; Tian J; Zhang L; Wang F; Zhu H; Lu G
Front Oncol; 2020; 10():1042. PubMed ID: 32766134
[No Abstract] [Full Text] [Related]
4. Value of
Yang B; Ji H; Zhong J; Ma L; Zhong J; Dong H; Zhou C; Duan S; Zhu C; Tian J; Zhang L; Wang F; Zhu H; Lu G
Front Oncol; 2020; 10():567160. PubMed ID: 33262942
[TBL] [Abstract][Full Text] [Related]
5. CT derived radiomic score for predicting the added benefit of adjuvant chemotherapy following surgery in stage I, II resectable non-small cell lung cancer: a retrospective multicohort study for outcome prediction.
Vaidya P; Bera K; Gupta A; Wang X; Corredor G; Fu P; Beig N; Prasanna P; Patil PD; Velu PD; Rajiah P; Gilkeson R; Feldman MD; Choi H; Velcheti V; Madabhushi A
Lancet Digit Health; 2020 Mar; 2(3):e116-e128. PubMed ID: 33334576
[TBL] [Abstract][Full Text] [Related]
6. Combination of computed tomography imaging-based radiomics and clinicopathological characteristics for predicting the clinical benefits of immune checkpoint inhibitors in lung cancer.
Yang B; Zhou L; Zhong J; Lv T; Li A; Ma L; Zhong J; Yin S; Huang L; Zhou C; Li X; Ge YQ; Tao X; Zhang L; Son Y; Lu G
Respir Res; 2021 Jun; 22(1):189. PubMed ID: 34183009
[TBL] [Abstract][Full Text] [Related]
7. A nomogram to predict the recurrence-free survival and analyze the utility of chemotherapy in stage IB non-small cell lung cancer.
Zhang Z; Xie S; Cai W; Hong ZN; Yang C; Lin Y; Zhu J; Lin Z; Christoph DC; Bohnenberger H; Kepka L; Brueckl WM; Van Houtte P; Kang M; Lin J
Transl Lung Cancer Res; 2022 Jan; 11(1):75-86. PubMed ID: 35242629
[TBL] [Abstract][Full Text] [Related]
8. Integrative nomogram of CT imaging, clinical, and hematological features for survival prediction of patients with locally advanced non-small cell lung cancer.
Wang L; Dong T; Xin B; Xu C; Guo M; Zhang H; Feng D; Wang X; Yu J
Eur Radiol; 2019 Jun; 29(6):2958-2967. PubMed ID: 30643940
[TBL] [Abstract][Full Text] [Related]
9. A CT-based deep learning radiomics nomogram for predicting the response to neoadjuvant chemotherapy in patients with locally advanced gastric cancer: A multicenter cohort study.
Cui Y; Zhang J; Li Z; Wei K; Lei Y; Ren J; Wu L; Shi Z; Meng X; Yang X; Gao X
EClinicalMedicine; 2022 Apr; 46():101348. PubMed ID: 35340629
[TBL] [Abstract][Full Text] [Related]
10. Prognostic nomogram for previously untreated patients with esophageal squamous cell carcinoma after esophagectomy followed by adjuvant chemotherapy.
Duan J; Deng T; Ying G; Huang D; Zhang H; Zhou L; Bai M; Li H; Yang H; Qu Y; Wang X; Ba Y
Jpn J Clin Oncol; 2016 Apr; 46(4):336-43. PubMed ID: 26819278
[TBL] [Abstract][Full Text] [Related]
11. Prediction and verification of survival in patients with non-small-cell lung cancer based on an integrated radiomics nomogram.
Li R; Peng H; Xue T; Li J; Ge Y; Wang G; Feng F
Clin Radiol; 2022 Mar; 77(3):e222-e230. PubMed ID: 34974912
[TBL] [Abstract][Full Text] [Related]
12. Radiomics nomogram for prediction disease-free survival and adjuvant chemotherapy benefits in patients with resected stage I lung adenocarcinoma.
Xie D; Wang TT; Huang SJ; Deng JJ; Ren YJ; Yang Y; Wu JQ; Zhang L; Fei K; Sun XW; She YL; Chen C
Transl Lung Cancer Res; 2020 Aug; 9(4):1112-1123. PubMed ID: 32953490
[TBL] [Abstract][Full Text] [Related]
13. A Prognostic Model of Non-Small Cell Lung Cancer With a Radiomics Nomogram in an Eastern Chinese Population.
Wang L; Liu A; Wang Z; Xu N; Zhou D; Qu T; Liu G; Wang J; Yang F; Guo X; Chi W; Xue F
Front Oncol; 2022; 12():816766. PubMed ID: 35774128
[TBL] [Abstract][Full Text] [Related]
14. Development of a radiomics nomogram based on the 2D and 3D CT features to predict the survival of non-small cell lung cancer patients.
Yang L; Yang J; Zhou X; Huang L; Zhao W; Wang T; Zhuang J; Tian J
Eur Radiol; 2019 May; 29(5):2196-2206. PubMed ID: 30523451
[TBL] [Abstract][Full Text] [Related]
15. Development of a computed tomography-based radiomics nomogram for prediction of transarterial chemoembolization refractoriness in hepatocellular carcinoma.
Niu XK; He XF
World J Gastroenterol; 2021 Jan; 27(2):189-207. PubMed ID: 33510559
[TBL] [Abstract][Full Text] [Related]
16. A Novel Nomogram including AJCC Stages Could Better Predict Survival for NSCLC Patients Who Underwent Surgery: A Large Population-Based Study.
Shang X; Yu H; Lin J; Li Z; Zhao C; Sun J; Wang H
J Oncol; 2020; 2020():7863984. PubMed ID: 32565807
[TBL] [Abstract][Full Text] [Related]
17. A Comprehensive Nomogram Combining CT Imaging with Clinical Features for Prediction of Lymph Node Metastasis in Stage I-IIIB Non-small Cell Lung Cancer.
Zheng X; Shao J; Zhou L; Wang L; Ge Y; Wang G; Feng F
Ther Innov Regul Sci; 2022 Jan; 56(1):155-167. PubMed ID: 34699046
[TBL] [Abstract][Full Text] [Related]
18. Radiomic signature-based nomogram to predict disease-free survival in stage II and III colon cancer.
Yao X; Sun C; Xiong F; Zhang X; Cheng J; Wang C; Ye Y; Hong N; Wang L; Liu Z; Meng X; Wang Y; Tian J
Eur J Radiol; 2020 Oct; 131():109205. PubMed ID: 32871292
[TBL] [Abstract][Full Text] [Related]
19. A potential biomarker based on clinical-radiomics nomogram for predicting survival and adjuvant chemotherapy benefit in resected node-negative, early-stage lung adenocarcinoma.
Ma X; Lv W; Wang C; Tu D; Qiao J; Fan C; Niu J; Zhou W; Liu Q; Xia L
J Thorac Dis; 2022 Jan; 14(1):1-17. PubMed ID: 35242363
[TBL] [Abstract][Full Text] [Related]
20. CT-based radiomics for predicting brain metastases as the first failure in patients with curatively resected locally advanced non-small cell lung cancer.
Sun F; Chen Y; Chen X; Sun X; Xing L
Eur J Radiol; 2021 Jan; 134():109411. PubMed ID: 33246270
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]